Papp, Kim A <br/><br/>
Biologic therapy in psoriasis: perspectives on associated risks and patient management.  [electronic resource] 

 -  Journal of cutaneous medicine and surgery   
 - 153-68 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1203-4754 
<br/><br/><label>Standard No.: </label>10.1177/120347541201600305  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Alefacept<br/>Algorithms<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>Biological Products--adverse effects<br/>Canada<br/>Dermatologic Agents--adverse effects<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Recombinant Fusion Proteins--adverse effects<br/>United States<br/>Ustekinumab